Literature DB >> 23830659

Urinary tract infection.

Lindsay E Nicolle1.   

Abstract

The urinary tract is a common source for life-threatening infections. Most patients with sepsis or septic shock from a urinary source have complicated urinary tract infection. This article explains the epidemiology, risk factors, and treatment. Effective management, appropriate collection of microbiology specimens, prompt initiation of antimicrobial therapy, source control, and supportive therapy are described.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bacteremia; Complicated urinary infection; Pyelonephritis; Urosepsis

Mesh：

Substances：

Year:  2013        PMID： 23830659     DOI： 10.1016/j.ccc.2013.03.014

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN： 0749-0704            Impact factor:   3.598


  16 in total

Review 1.  New and developing diagnostic technologies for urinary tract infections.

Authors:  Michael Davenport; Kathleen E Mach; Linda M Dairiki Shortliffe; Niaz Banaei; Tza-Huei Wang; Joseph C Liao
Journal:  Nat Rev Urol       Date:  2017-03-01       Impact factor: 14.432

2.  A new anti-microbial combination prolongs the latency period, reduces acute histologic chorioamnionitis as well as funisitis, and improves neonatal outcomes in preterm PROM.

Authors:  JoonHo Lee; Roberto Romero; Sun Min Kim; Piya Chaemsaithong; Chan-Wook Park; Joong Shin Park; Jong Kwan Jun; Bo Hyun Yoon
Journal:  J Matern Fetal Neonatal Med       Date:  2015-09-16

Review 3.  Risk Factors for Nosocomial Bacteremia Secondary to Urinary Catheter-Associated Bacteriuria: A Systematic Review.

Authors:  Laurie J Conway; Eileen J Carter; Elaine L Larson
Journal:  Urol Nurs       Date:  2015 Jul-Aug

4.  Upper and lower urinary tract infections can be detected early but not be discriminated by urinary NGAL in adults.

Authors:  Anja Urbschat; Nicholas Obermüller; Patrick Paulus; Manuel Reissig; Peyman Hadji; Rainer Hofmann; Helmut Geiger; Stefan Gauer
Journal:  Int Urol Nephrol       Date:  2014-09-14       Impact factor: 2.370

5.  Recommendations for the empirical treatment of complicated urinary tract infections using surveillance data on antimicrobial resistance in the Netherlands.

Authors:  Maike Koningstein; Akke K van der Bij; Marlieke E A de Kraker; Jos C Monen; Jan Muilwijk; Sabine C de Greeff; Suzanne E Geerlings; Maurine A Leverstein-van Hall; Maurine A Leverstein- van Hall
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

6.  Biomimetic Bacterial Identification Platform Based on Thermal Wave Transport Analysis (TWTA) through Surface-Imprinted Polymers.

Authors:  Erik Steen Redeker; Kasper Eersels; Onno Akkermans; Jeroen Royakkers; Simba Dyson; Kunya Nurekeyeva; Beniamino Ferrando; Peter Cornelis; Marloes Peeters; Patrick Wagner; Hanne Diliën; Bart van Grinsven; Thomas Jan Cleij
Journal:  ACS Infect Dis       Date:  2017-04-11       Impact factor: 5.084

7.  Pivmecillinam compared to other antimicrobials for community-acquired urinary tract infections with Escherichia coli, ESBL-producing or not - a retrospective cohort study.

Authors:  Filip Jansåker; Jonas Bredtoft Boel; Sara Thønnings; Frederik Boëtius Hertz; Katrine Hartung Hansen; Niels Frimodt-Møller; Jenny Dahl Knudsen
Journal:  Infect Drug Resist       Date:  2019-06-13       Impact factor: 4.003

8.  Comparison of lower genital tract microbiota in HIV-infected and uninfected women from Rwanda and the US.

Authors:  Lorie Benning; Elizabeth T Golub; Kathryn Anastos; Audrey L French; Mardge Cohen; Douglas Gilbert; Patrick Gillevet; Elisaphane Munyazesa; Alan L Landay; Masoumeh Sikaroodi; Gregory T Spear
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

9.  Risk of Cancer after Lower Urinary Tract Infection: A Population-Based Cohort Study.

Authors:  Chia-Hung Huang; Ying-Hsiang Chou; Han-Wei Yeh; Jing-Yang Huang; Shun-Fa Yang; Chao-Bin Yeh
Journal:  Int J Environ Res Public Health       Date:  2019-01-30       Impact factor: 3.390

10.  Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.

Authors:  Jianguo Li; Mark Lovern; Michelle L Green; Joannellyn Chiu; Diansong Zhou; Craig Comisar; Yuan Xiong; Jeremy Hing; Merran MacPherson; James G Wright; Todd Riccobene; Timothy J Carrothers; Shampa Das
Journal:  Clin Transl Sci       Date:  2018-09-28       Impact factor: 4.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.